BioPharma Drug Discovery
Insilico Medicine and Hygtia Therapeutics, an incubatee of Shenzhen Pengfu Fund of Fosun Health Capital and Fosun Pharma, have entered into an exclusive ...
January 22, 2026 | News
- In head-to-head non-human primate (NHP) studies, average observed half-life of ASC37 was approximately 17 days, 7-fold longer than retatrutide, whic...
January 21, 2026 | News
D3 Bio, a global clinical‑stage biotechnology company focused on developing transformative oncology therapeutics, announced that the U.S. Foo...
January 20, 2026 | News
- UCSD's Dr. Davey Smith, former ACTIV-2 Protocol Chair, endorses 'Xafty' as "The weapon to end the virus war." - Announces "One Drug, Two Tracks...
January 19, 2026 | News
From January 12 to 15, 2026, the 44th J.P. Morgan Healthcare Conference (JPMHC) was held in San Francisco, California, USA. Dr. Ge Michael, President and C...
January 19, 2026 | News
Marks a major milestone in Zylox-Tonbridge's long-term commitment to global expansion Builds an integrated global commercialization platform to accel...
January 19, 2026 | News
ElpasBio Holdings ("ElpasBio"), a leading clinical-stage biotechnology company focused on regenerative medicine, announced that it has entered into a colla...
January 15, 2026 | News
Zonsen PepLib Biotech Inc. announced that it has entered into a worldwide license agreement with Novartis for an undisclosed peptide-based asset in t...
January 15, 2026 | News
The breakthrough tackles a longstanding challenge in genetic medicine with the goal of developing a new generation of curative cell and gene therapies. ...
January 14, 2026 | News
WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that two of its manufacturing ...
January 14, 2026 | News
TetraScience, the Scientific Data and AI company, announced a collaboration with Thermo Fisher Scientific Inc., the world leader in serving science, with a...
January 14, 2026 | News
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced a strategic collaboration with NVIDIA to power AI-based solutions...
January 13, 2026 | News
- Phase 2 Initiation Strengthens Global First-in-Class Potential for Clover's Protein-Based RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candid...
January 13, 2026 | News
Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that China's National Medical Products Administration (NMPA) has approved the...
January 12, 2026 | News
Most Read
Bio Jobs
News
Editor Picks